Gene therapy for a murine model of eosinophilic esophagitis
Abstract
Background: Eosinophils are specialized granulocytic effector cells that store and release highly active mediators used in immune defense. Eosinophils are also implicated in the pathogenesis of allergic disorders, including eosinophilic esophagitis (EoE), a chronic disorder characterized by infiltration of eosinophils into the esophagus and release of mediators that damage tissue, resulting in gastrointestinal morbidity, food impaction, and dysphagia. Treatment with elimination diets and/or topical corticosteroid therapy slow disease progression, but are complicated by adverse effects, limited compliance, and loss of response to therapy. We hypothesized that a single administration of an adeno‐associated virus (AAV) coding for an anti‐eosinophil monoclonal antibody that induces eosinophil clearance (anti‐Siglec‐F) would treat on a persistent basis a murine model of EoE.Methods: A mouse model of peanut‐induced EoE that mimics the human disease was established by sensitization and challenge with peanut extract. After challenge, these mice exhibited an EoE phenotype demonstrated by elevated levels of blood eosinophils, infiltration of eosinophils in the esophagus with associated esophageal remodeling and food impaction.Results: The mice were treated with a single intravenous administration (1011 genome copies) of AAVrh.10mAnti‐Eos, a serotype rh.10 AAV vector coding for an anti‐Siglec‐F monoclonal antibody. Vector administration resulted in persistent, high levels of anti‐Siglec‐F antibody expression. Administration of AAVrh.10mAnti‐Eos to the mouse model of EoE reduced blood (P < 0.02) and esophageal eosinophil numbers (P < 0.002) protected from esophageal tissue remodeling and minimized food impaction.Conclusion: These results suggest that a single treatment with AAVrh.10mAnti‐Eos has the potential to provide persistent therapeutic benefit to patients with EoE.Keywords
This publication has 65 references indexed in Scilit:
- A reliable and feasible qPCR strategy for titrating AAV vectorsMedical Science Monitor Basic Research, 2013
- Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort StudyPLOS ONE, 2012
- Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse modelClinical Immunology, 2009
- Mechanism of Eosinophilic EsophagitisImmunology and Allergy Clinics of North America, 2009
- Siglec‐8 on human eosinophils and mast cells, and Siglec‐F on murine eosinophils, are functionally related inhibitory receptorsClinical & Experimental Allergy, 2009
- Siglec‐F antibody administration to mice selectively reduces blood and tissue eosinophilsAllergy, 2008
- Interleukin-5 Priming of Human Eosinophils Alters Siglec-8–Mediated Apoptosis PathwaysAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced EosinophiliaGastroenterology, 2008
- Anti-IgE treatment of eosinophil-associated gastrointestinal disordersJournal of Allergy and Clinical Immunology, 2007